Bee Venom Effect on Glioblastoma Cells Viability and Gelatinase Secretion

Overview

Journal Front Neurosci

Date 2022 Feb 28

PMID 35221898

Authors

Agata Malek

Joanna Kocot

Kamila Mitrowska

Andrzej Posyniak

Jacek Kurzepa

Affiliations

Soon will be listed here.

Abstract

Background: The involvement of MMP-2 and MMP-9 in the pathogenesis of various kinds of cancers including glioblastoma is well documented. The evaluation of the anticancer potential of honey bee () venom (BV) consisting of the inhibition of MMP-2 and MMP-9 secretion in a glioblastoma cell culture model was the aim of the study.

Methods: 8-MG-BA and GAMG human primary glioblastoma cell lines vs. HT-22 mouse hippocampal neuronal cells were applied for the study. The BV dose (0.5, 1.0, 1.25, 1.5, 1.75, 2.0, 2.5, and 5.0 μg/ml) and time-dependent (24, 48, 72 h) cytotoxicity was evaluated with the tetrazolium-based colorimetric assay (MTT test). MMP-2 and MMP-9 activities in the cell culture medium under different BV concentrations were determined by gelatin zymography.

Results: A dose and time-dependent BV effect on cytotoxicity of both glioblastoma cell lines and hippocampus line was observed. The weakest, but statistically important effect was exerted by BV on HT-22 cells. The greatest cytotoxic effect of BV was observed on the 8-MG-BA line, where a statistically significant reduction in viability was observed at the lowest BV dose and the shortest incubation time. The reduction of both gelatinases secretion was observed at 8-MG-BA and GAMG lines without significant effect of HT-22 cell line.

Conclusion: studies indicate that BV has both cytotoxic and inhibitory effects on the secretion of MMP-2 and MMP-9 in selected lines of glioma, suggesting anticancer properties of BV.

Citing Articles

Effect of Bee Venom on Glioblastoma Cancer: In Vitro and In Vivo Studies.

Chahla C, Rima M, Mouawad C, Roufayel R, Kovacic H, El Obeid D Molecules. 2024; 29(16).

PMID: 39203027 PMC: 11357583. DOI: 10.3390/molecules29163950.

Harnessing the power of bee venom for therapeutic and regenerative medical applications: an updated review.

Sadek K, Shib N, Taher E, Rashed F, Shukry M, Atia G Front Pharmacol. 2024; 15:1412245.

PMID: 39092234 PMC: 11291246. DOI: 10.3389/fphar.2024.1412245.

Can Bee Venom Be Used as Anticancer Agent in Modern Medicine?.

Malek A, Strzemski M, Kurzepa J, Kurzepa J Cancers (Basel). 2023; 15(14).

PMID: 37509375 PMC: 10378503. DOI: 10.3390/cancers15143714.

Bee venom-loaded EGFR-targeting peptide-coupled chitosan nanoparticles for effective therapy of hepatocellular carcinoma by inhibiting EGFR-mediated MEK/ERK pathway.

Abdulmalek S, Mostafa N, Gomaa M, El-Kersh M, Elkady A, Balbaa M PLoS One. 2022; 17(8):e0272776.

PMID: 35947632 PMC: 9365195. DOI: 10.1371/journal.pone.0272776.

References

Zheng J, Lee H, Ham Y, Song H, Song M, Hong J . Anti-cancer effect of bee venom on colon cancer cell growth by activation of death receptors and inhibition of nuclear factor kappa B. Oncotarget. 2015; 6(42):44437-51. PMC: 4792567. DOI: 10.18632/oncotarget.6295. View

Linhares P, Carvalho B, Vaz R, Costa B . Glioblastoma: Is There Any Blood Biomarker with True Clinical Relevance?. Int J Mol Sci. 2020; 21(16). PMC: 7461098. DOI: 10.3390/ijms21165809. View

McAllister S, Chan C, Taft R, Luu T, Abood M, Moore D . Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells. J Neurooncol. 2005; 74(1):31-40. DOI: 10.1007/s11060-004-5950-2. View

Lee K, Kim B, Yoon H, Choi Y, Jin B . Secapin, a bee venom peptide, exhibits anti-fibrinolytic, anti-elastolytic, and anti-microbial activities. Dev Comp Immunol. 2016; 63:27-35. DOI: 10.1016/j.dci.2016.05.011. View

Ricci S, DEsposito V, Oriente F, Formisano P, Di Carlo A . Substrate-zymography: a still worthwhile method for gelatinases analysis in biological samples. Clin Chem Lab Med. 2015; 54(8):1281-90. DOI: 10.1515/cclm-2015-0668. View

Lowrey G, Henderson N, Blakey J, Corne J, Johnson S . MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD. Respir Med. 2008; 102(6):845-51. DOI: 10.1016/j.rmed.2008.01.006. View

Jamasbi E, Lucky S, Li W, Hossain M, Gopalakrishnakone P, Separovic F . Effect of dimerized melittin on gastric cancer cells and antibacterial activity. Amino Acids. 2018; 50(8):1101-1110. DOI: 10.1007/s00726-018-2587-6. View

Choo Y, Lee K, Yoon H, Kim B, Sohn M, Roh J . Dual function of a bee venom serine protease: prophenoloxidase-activating factor in arthropods and fibrin(ogen)olytic enzyme in mammals. PLoS One. 2010; 5(5):e10393. PMC: 2862700. DOI: 10.1371/journal.pone.0010393. View

Gu H, Han S, Park K . Therapeutic Effects of Apamin as a Bee Venom Component for Non-Neoplastic Disease. Toxins (Basel). 2020; 12(3). PMC: 7150898. DOI: 10.3390/toxins12030195. View

10.

Wolff J, Trilling T, Molenkamp G, Egeler R, Jurgens H . Chemosensitivity of glioma cells in vitro: a meta analysis. J Cancer Res Clin Oncol. 1999; 125(8-9):481-6. DOI: 10.1007/s004320050305. View

11.

Orsolic N . Bee venom in cancer therapy. Cancer Metastasis Rev. 2011; 31(1-2):173-94. DOI: 10.1007/s10555-011-9339-3. View

12.

Marcu J, Christian R, Lau D, Zielinski A, Horowitz M, Lee J . Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival. Mol Cancer Ther. 2010; 9(1):180-9. PMC: 2806496. DOI: 10.1158/1535-7163.MCT-09-0407. View

13.

Liu X, Chen D, Xie L, Zhang R . Effect of honey bee venom on proliferation of K1735M2 mouse melanoma cells in-vitro and growth of murine B16 melanomas in-vivo. J Pharm Pharmacol. 2002; 54(8):1083-9. DOI: 10.1211/002235702320266235. View

14.

Kasozi K, Niedbala G, Alqarni M, Zirintunda G, Ssempijja F, Musinguzi S . Bee Venom-A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections. Front Public Health. 2020; 8:594458. PMC: 7758230. DOI: 10.3389/fpubh.2020.594458. View

15.

Rady I, Siddiqui I, Rady M, Mukhtar H . Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer Lett. 2017; 402:16-31. PMC: 5682937. DOI: 10.1016/j.canlet.2017.05.010. View

16.

Golab P, Boguszewska-Czubara A, Kielbus M, Kurzepa J . The rtPA increases MMP-9 activity in serum during ischaemic stroke. Neurol Neurochir Pol. 2014; 48(5):309-14. DOI: 10.1016/j.pjnns.2014.07.012. View

17.

Zhang S, Liu Y, Ye Y, Wang X, Lin L, Xiao L . Bee venom therapy: Potential mechanisms and therapeutic applications. Toxicon. 2018; 148:64-73. DOI: 10.1016/j.toxicon.2018.04.012. View

18.

Galanti G, Fisher T, Kventsel I, Shoham J, Gallily R, Mechoulam R . Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells. Acta Oncol. 2007; 47(6):1062-70. DOI: 10.1080/02841860701678787. View

19.

Park H, Kyung S, Lee K, Kim B, Choi Y, Yoon H . Dual function of a bee (Apis cerana) inhibitor cysteine knot peptide that acts as an antifungal peptide and insecticidal venom toxin. Dev Comp Immunol. 2014; 47(2):247-53. DOI: 10.1016/j.dci.2014.08.001. View

20.

Upadhyay R . Drug delivery systems, CNS protection, and the blood brain barrier. Biomed Res Int. 2014; 2014:869269. PMC: 4127280. DOI: 10.1155/2014/869269. View